Luis Perez-Jurado


Pompeu Fabra University Barcelona

Luis A. Pérez-Jurado, MD, PhD, is Clinical Geneticist in the Women and Children Health Network, Senior Research Fellow in the South Australian Health and Medical Research Institute (SAHMRI) and Clinical Professor in the University of Adelaide, Australia (since 2017). He has also joint appointments as Professor of Genetics at Universitat Pompeu Fabra (UPF) (since 2010), and Senior Consultant and Group leader in the Neuroscience Program of the Hospital del Mar Research Institute, in Barcelona, Spain. He is a Steering Committee Member and Coordinator of Formation in the Spanish Network Centre for Biomedical Research on Rare Diseases (CIBERER) (since 2007). His research group has done significant contributions to the field of genetics of childhood onset neurodevelopmental disorders. The main goal of his research is to facilitate and drive translational research into the prevention of childhood disability integrating clinical practice with genetics and genomic tools. He got his Medical Degree (1983) and PhD (extraordinary award, 1992) in the Autonomous University of Madrid, and holds medical specialties in Family Practice (Granada, Spain), Paediatrics (Madrid, Spain), Clinical Genetics and Clinical Molecular Genetics (Stanford University, USA). Following pre- and postdoctoral training in the USA (1990-95, Vanderbilt and Stanford Universities), he has held several positions in Spain since 1996, including the Coordination of the Genetics Program of the Hospital Vall d’Hebron in Barcelona (2006-2009), being Director the EBMG-accredited Master Program in Genetic Counselling of the UPF. He has served on various advisory boards, lead a Consolidated Research Group of Catalonia since 2005, and is co-founder of qGenomics Laboratory (2009). He has co-authored more than 150 peer-reviewed publications mostly in the field of human genetics and received several distinctions (ICREA-Acadèmia and City of Barcelona Awards among others). He currently coordinates the Programs for Undiagnosed Rare Diseases of Catalonia (URDCat) and the CIBERER (ENoD).